Biostatiq ApS: Financial statements 2025
CVR: 40966285
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Biostatiq ApS (CVR 40966285) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 808,404 and a net result of DKK 247,002 compared with DKK -4,883 the year before. That is an increase of 848.1% compared with the year before. Equity in the 2025 report amounted to DKK 299,178. The solvency ratio was 27.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 808,404
- Profit/Loss
- DKK 247,002
- Equity
- DKK 299,178
- Total Assets
- DKK 1,075,315
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 808 t. | 247 t. | 299 t. | 1 |
| 2024 | - | 85 t. | -5 t. | 52 t. | 1 |
| 2023 | - | 417 t. | -875 | 57 t. | 1 |
| 2022 | - | 102 t. | 73 t. | 58 t. | 0 |
| 2021 | - | -8 t. | -21 t. | -16 t. | 0 |
Official annual report
How creditworthy is Biostatiq ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of August 29, 2025, Arkenstone Capital ApS is registered as an owner of Biostatiq ApS with an ownership share of 25%.
Biostatiq ApS has published its annual report for 2024. Gross profit came to DKK 85,263, and the net result was DKK -4,883.
About Biostatiq ApS
Biostatiq ApS is a Danish company of the type Anpartsselskab based in Gilleleje, founded in 2019. The company is registered under the industry Fremstilling af andet elektrisk udstyr. The company was previously named Stealth Induction ApS. The management consists of Carsten Dan Petersen. The company is owned by Frank Friis Nielsen and Arkenstone Capital ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 808,404 and a net result of DKK 247,002 compared with DKK -4,883 the year before. Equity in the 2025 report amounted to DKK 299,178.